Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

UBS
Johnson and Johnson
Covington
Fish and Richardson
Accenture
Merck
US Army
McKinsey
Citi
Fuji

Generated: December 11, 2017

DrugPatentWatch Database Preview

ZYFLO CR Drug Profile

« Back to Dashboard

When do Zyflo Cr patents expire, and when can generic versions of Zyflo Cr launch?

Zyflo Cr is a drug marketed by Chiesi Usa Inc and is included in one NDA.

The generic ingredient in ZYFLO CR is zileuton. There are eight drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the zileuton profile page.

US Patents and Regulatory Information

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
Chiesi Usa IncZYFLO CRzileutonTABLET, EXTENDED RELEASE;ORAL022052-001May 30, 2007ABRXYesYes► Subscribe► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: ZYFLO CR

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Chiesi Usa IncZYFLO CRzileutonTABLET, EXTENDED RELEASE;ORAL022052-001May 30, 2007► Subscribe► Subscribe
Chiesi Usa IncZYFLO CRzileutonTABLET, EXTENDED RELEASE;ORAL022052-001May 30, 2007► Subscribe► Subscribe
Chiesi Usa IncZYFLO CRzileutonTABLET, EXTENDED RELEASE;ORAL022052-001May 30, 2007► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Farmers Insurance
Argus Health
Medtronic
Moodys
Express Scripts
Accenture
Deloitte
Baxter
Cipla
Daiichi Sankyo

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot